Reinsurers must adapt strategies to align with risk introduced by GLP-1 therapies: Gallagher Re
Reinsurance News - Mar 28, 2025
Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 receptor agonists on medical trends and reinsurance. According to the report, as these therapies continue to reshape medical trends and insurance structures, reinsurance provider...
Recommended Articles
Posted: Apr 17, 2025
Speaking during Marsh McLennan’s Q1 2025 earnings call this afternoon, Dean Klisura, CEO of re...
Posted: Apr 17, 2025
Amwins Special Risk Underwriters (SRU) has launched its new Excess Casualty Sidecar Program, offerin...
Posted: Apr 17, 2025
Independent insurance broker Lockton has announced the appointment of Chris DiLullo as its first U.S...